![](/img/cover-not-exists.png)
Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenström macroglobulinemia does not indicate failure of response
Irene M. Ghobrial, Daniel Z. Uslan, Timothy G. Call, Thomas E. Witzig, Morie A. GertzVolume:
77
Year:
2004
Language:
english
Pages:
2
DOI:
10.1002/ajh.20207
File:
PDF, 75 KB
english, 2004